Wall Street Loses Faith in Fortive’s Growth Trajectory

Major Institutions Slash Targets

A wave of skepticism has swept through Wall Street regarding Fortive Corp.’s near-term prospects, as multiple prominent financial institutions dramatically downgraded their outlook for the industrial conglomerate. This collective shift in sentiment follows disappointing quarterly results and raises questions about the company’s strategic direction following its recent corporate separation.

The reassessment began in earnest when Morgan Stanley downgraded Fortive from “Overweight” to “Equal Weight” on Tuesday. In a particularly stark adjustment, the firm slashed its price target from $90 to $50 per share. This move triggered similar actions across the sector: Barclays reduced its target from $58 to $54, Truist Securities adjusted from $60 to $55, and Wells Fargo cut its projection from $72 to $55.